SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19

DOI https://doi.org/10.4084/mjhid.2020.031

Article Sidebar

PDF HTML
Published: Apr 27, 2020
Letters to Editor

Issue
Vol. 12 No. 1 (2020): Mediterranean Journal of Hematology and Infectious Diseases, Volume 12, 2020
Pages
e2020031
Keywords
CML, SARS-CoV-2, COVID-19, TKI, ABL
Statistics
Abstract Views: 1346

Share it
How to Cite
Abruzzese, E., luciano, luigia, D’Agostino, F., Trawinska, M. M., Pane, F. and de Fabritiis, P. (2020) “SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection: CML and COVID-19 ”, Mediterranean Journal of Hematology and Infectious Diseases, 12(1), p. e2020031. doi: 10.4084/mjhid.2020.031.

Main Article Content

Elisabetta Abruzzese
Hematology, S. Eugenio Hospital, Tor Vergata UniversityPiazzale dell’Umanesimo 1000144 Rome, Italy, Italy.
Luigia Luciano
Hematology, Federico II Università, Napoli, Italy, Italy.
Francesco D'Agostino
Hematology, Federico II Università, Napoli, Italy, Italy.
Malgorzata Monika Trawinska
Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Roma, Italy, Italy.
Fabrizio Pane
Hematology, Federico II Università, Napoli, Italy, Italy.
Paolo de Fabritiis
Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Roma, Italy, Italy.
(*) Corresponding Author:

Abstract

no abstract available


Aknowledgements:


We thank professor Nathan Tubliz, dept. Biology, University of Oregon, for his insightful support.

Downloads month by month

Downloads

Download data is not yet available.

Article Details

Most read articles by the same author(s)

1 2 > >>